Dr. Samy Bendjemil, MD, MPH

Dr. Dr. Samy Bendjemil, MD, MPH

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Jaffar KhanJaffar Khan
Jaffar Khan
Asad UllahAsad Ullah
Asad Ullah
AWAbdul Waheed
Abdul Waheed
Nabin R KarkiNabin R Karki
Nabin R Karki
NANawaraj Adhikari
Nawaraj Adhikari
HMHector Mesa
Hector Mesa
Introduction: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasm of the gastrointestinal (GI) system. Most GISTs originate from the interstitial cells of Cajal (ICC), the pacemaker cell situated between the circular and longitudinal layers of the muscularis propria along the GI tract. In this population-based study using the SEER database, we sought to identify demographic, clinical, and pathologic factors that affect the prognosis and survival of patients with this neoplasm. Molecular genetic advances, current management guidelines, and advances in targeted therapy are discussed. Methods: Demographic and clinical data from GIST patients were retrieved from the SEER research plus database for the period 2000–2018. Statistical analysis was performed with IBM SPSS® v20.2 software using the Chi-square test, paired t-test, multivariate analysis, and Kaplan–Meier functions. Results: A total of 10,833 patients with GIST were identified. Most patients were between 60–74 years of age: 40%, Caucasian: 68%, and the male to female ratio was 1.1:1. The most common primary tumor sites were stomach: 63%, small intestine: 30%, rectum: 3%, and esophagus: 0.7%. When reported, the grade of differentiation was well: 38%, moderately: 32%, undifferentiated: 19%, poorly: 12%. The size of most tumors ranged between 6–10 cm: 36% and they were treated by surgical intervention: 82% and/or chemotherapy/targeted therapy: 39%. The stage was localized: 66%, advanced: 19%, and regional: 15%. The 5-year survival was 74% (95% confidence interval (95% CI) = 72.6–74.7), and the 5-year cause-specific survival 82% (95% CI = 80.7–82.6). The 5-year cause-specific survival by treatment included surgery at 86% (95% CI = 85.4–87.3), chemotherapy/targeted therapy with or without surgery at 77% (95% CI = 75.7–78.9), and radiation at 75% (95% CI = 74.5–80). On multivariable analysis tumor size > 5 cm, poorly and undifferentiated grade, age > 60, and distant metastases at presentation were associated with worse overall survival. Conclusion: GISTs comprise 1–2% of malignancies of the GI tract, usually affect male Caucasians between the ages of 60 and 74 years, most tumors occur in the stomach and small intestine, and are usually >5 cm, but still localized, at the time of diagnosis. Most tumors receive multimodality surgical and chemotherapy/targeted therapy treatment, with a 5-year overall survival of 74% and cause-specific survival of 82%. GIST patients would benefit from enrollment in large clinical trials to establish better therapy guidelines for unresectable, treatment-refractory, and recurrent tumors.

8 January 2020 in Journal of Burn Care & Research
Verified
Journal Article
Closed access
PDF file
ELErica L W Lester
Erica L W Lester
JDJustin E Dvorak
Justin E Dvorak
PMPatrick J Maluso
Patrick J Maluso
Dr. Samy Bendjemil, MD, MPHDr. Samy Bendjemil, MD, MPH
Dr. Samy Bendjemil, MD, MPH
TMThomas Messer
Thomas Messer
FBFaran Bokhari
Faran Bokhari
Despite the fact that obesity is a known risk factor for comorbidities and complications, there is evidence suggesting a survival advantage for patients classified by body mass index (BMI) as overweight or obese. Investigated in various clinical areas, this “Obesity Paradox” has yet to be explored in the burn patient population. We sought to clarify whether this paradigm exists in burn patients. Data collected on 519 adult patients admitted to an American Burn Association Verified Burn Center between 2009 and 2017 was utilized. Univariable and multivariable logistic regression were used to determine the association between in-hospital mortality and BMI classifications (underweight 40 kg/m2). For every kg/m2 increase in BMI, the odds of death decreased, with an adjusted odds ratio of 0.856 (95% confidence interval [CI] 0.767 to 0.956). When adjusted for total BSA (TBSA), being obesity class I was associated with an adjusted odds ratio of mortality of 0.0166 (95% CI 0.000332 to 0.833). The adjusted odds ratio for mortality for underweight patients was 4.13 (95% CI 0.416 to 41.055). There was no statistically significant difference in odds of mortality between the normal and overweight BMI categories. In conclusion, the obesity paradox exists in burn care: further investigation is needed to elucidate what specific phenotypic aspects confer this benefit and how these can enhance the care of burn patients.

1 October 2015 in Waterlines
Verified
Journal Article
Closed access
JBJessica Brooks
Jessica Brooks
AAAlexandra Marion Adams
Alexandra Marion Adams
Dr. Samy Bendjemil, MD, MPHDr. Samy Bendjemil, MD, MPH
Dr. Samy Bendjemil, MD, MPH
JRJason Rosenfeld
Jason Rosenfeld
Although interventions that emphasize the role of knowledge in invoking behaviour change have recently become unpopular, the Community Health Club (CHC) model has demonstrated how group knowledge, consensus building, and peer pressure can be applied to achieve hygiene behaviour change. To date, the model has predominantly been implemented in rural settings, with limited testing in urban communities. In 2012, CHCs started in Haiti as a grassroots initiative, growing from six clubs in six Port-au-Prince communities to 66 clubs across 30 communities in 2015. This paper focuses on the 23 clubs formed between March 2012 and July 2014, when a retrospective process and outcome evaluation was conducted. Using a mixed methods study design, this evaluation used interviews with CHC facilitators and household surveys in three case neighbourhoods to assess how the CHC model was implemented and if differences exist between CHC graduates and non-members. The CHCs have successfully facilitated social bonding, while gradu...

5 January 2025 in Trauma & Case Reports
Verified
Journal Article
Open access
Dr. Samy Bendjemil, MD, MPHDr. Samy Bendjemil, MD, MPH
Dr. Samy Bendjemil, MD, MPH
JFJoseph D. Forrester
Joseph D. Forrester
Blunt thoracic trauma, often leading to rib fractures and costal cartilage injuries, is a significant cause of morbidity and mortality in trauma patients. Rib fractures, occurring in up to 40 % of cases, frequently accompany other injuries and are commonly diagnosed. Conversely, costal cartilage fractures are challenging to diagnose, often necessitating advanced imaging techniques, exist on a spectrum from a simple fracture to complete costal margin disruption, and are likely underreported. The mainstay of therapy for costal cartilage injuries is pain management, although for more displaced or symptomatic fractures open reduction and internal fixation may offer benefit. Our paper presents a case series of two patients with costal cartilage injuries resulting from surfing-related trauma. These cases describe a unique injury pattern in surfing and successful surgical intervention for mal-union and ossification of fractured costal cartilage. Our observations contribute to a growing body of literature describing this injury pattern and treatment of these costal cartilage injuries.

8 March 2019 in Journal of Burn Care & Research
Verified
Journal Article
Closed access
PDF file
ELE L Lester
E L Lester
PMP J Maluso
P J Maluso
JDJ E Dvorak
J E Dvorak
Dr. Samy Bendjemil, MD, MPHDr. Samy Bendjemil, MD, MPH
Dr. Samy Bendjemil, MD, MPH
SPS Poulakidas
S Poulakidas
FBF Bokhari
F Bokhari
Despite the fact that obesity is a known risk factor for comorbidities and complications, there is evidence suggesting a survival advantage for patients classified by body mass index (BMI) as overweight or obese. Investigated in various clinical areas, this “BMI paradox” has yet to be explored in the burn patient population. We sought to clarify whether this paradigm exists in burn patients. Data collected on 519 adult patients admitted to an American Burn Association/American College of Surgeons Verified Burn Center between 2009 and 2017 was utilized. Univariable and multivariable logistic regression were used to determine the association between in-hospital mortality and the National Heart, Lung and Blood Institute(NIH) BMI classifications (underweight 40 kg/m2). The mean BMI of inpatients treated for burns was 29.56 (SD 10.64). For every kg/m2 increase in BMI, the odds of death decreased, with an adjusted odds ratio 0.82 (95% CI 0.71–0.96; p<0.01). When adjusted for total burn surface area, being in the obese class I rather than the normal classification was associated with an adjusted odds ratio of mortality of 0.032 (95% CI 0.0012 - 0.92; p40 kg/m2 had an odds ratio of 0.00. The adjusted odds ratio if underweight was 12.11 (95%CI 1.55–94.62; p<0.05). There was no statistically significant difference in odds of mortality between a normal and an overweight BMI. The “BMI paradox” exists in burn care. Further investigation is needed to elucidate what specific phenotypic aspects confer this benefit and how these can enhance the care of burn patients. Alters understanding of predictors of outcome.

1 May 2018 in Gastroenterology
Verified
Journal Article
Closed access
SJShaneeta Johnson
Shaneeta Johnson
CMCarolyn Moore
Carolyn Moore
Dr. Samy Bendjemil, MD, MPHDr. Samy Bendjemil, MD, MPH
Dr. Samy Bendjemil, MD, MPH
KUKayellen Umeakunne
Kayellen Umeakunne
LHLarry Hobson
Larry Hobson
ODOmar K. Danner
Omar K. Danner